Clinical trial planned for novel Alzheimer's Disease therapy at Usask

Dr. Andrew Kirk is a co-lead on the trial, members of the research team include Dr. Megan O'Connell

A University of Saskatchewan clinical trial being led by Dr. Ron Geyer and RaDAR Team member Dr. Andrew Kirk will be testing a novel therapy for Alzheimer's Disease. The clinical research team also includes RaDAR team member Dr. Megan O'Connell.

The full article about this exciting Phase II clinical trial was prepared by the College of Medicine.